Clearside Biomedical, Inc.
CLSD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$34 | -$32 | -$33 | $0 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5 | $4 | $5 | $5 |
| Change in WC | -$2 | $1 | $11 | -$15 |
| Other Non-Cash | $7 | $9 | $3 | -$1 |
| Operating Cash Flow | -$25 | -$18 | -$13 | -$11 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$2 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$17 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $17 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | -$2 | -$0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $31 | $0 |
| Stock Issued | $16 | $2 | $1 | $23 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$1 | $0 | $0 |
| Financing Cash Flow | $16 | $0 | $31 | $24 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$9 | -$19 | $18 | $13 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $29 | $48 | $31 | $18 |
| End Cash | $20 | $29 | $48 | $31 |
| Free Cash Flow | -$26 | -$20 | -$14 | -$11 |